# Bevacizumab w / Temozolomide PET & Vascular MRI For GBM

> **NCT01987830** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 13 (actual)

## Conditions studied

- Recurrent Glioblastoma

## Interventions

- **DEVICE:** MRI-PET
- **DEVICE:** TMZ-PET

## Key facts

- **NCT ID:** NCT01987830
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2019-04
- **Final completion:** 2019-04
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2020-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01987830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01987830, "Bevacizumab w / Temozolomide PET & Vascular MRI For GBM". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01987830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*